Breaking News Instant updates and real-time market news.

TRIP

TripAdvisor

$26.12 /

-1.42 (-5.16%)

 06:41
12/01/20
 12/01
06:41
 12/01/20
06:41

TripAdvisor initiated with an Outperform at Bernstein

Bernstein analyst Richard Clarke initiated coverage of TripAdvisor with an Outperform rating and $35 price target as he started coverage on the Online Travel Agencies group with a cautious long-term view. While TripAdvisor's core metasearch business is in active decline, he sees opportunities for growth in Experiences as well as Restaurants & B2B services, Clarke said.
TRIP TripAdvisor
$26.12 /

-1.42 (-5.16%)

11/30/20 Bernstein
TripAdvisor initiated with an Outperform at Bernstein
08/18/20 DA Davidson
TripAdvisor price target raised to $26 from $23 at DA Davidson
08/10/20 RBC Capital
TripAdvisor price target raised to $24 from $19 at RBC Capital
08/10/20 Stifel
TripAdvisor price target raised to $21 from $15 at Stifel

TODAY'S FREE FLY STORIES

Hot Stocks
Urban One trading halted, volatility trading pause  10:50
01/19/21
01/19
10:50
01/19/21
10:50
UONE

Urban One

$5.71 /

-0.19 (-3.22%)

 
ShowHide Related Items >><<
UONE Urban One
$5.71 /

-0.19 (-3.22%)

11/25/20
Urban One CEO buys 719K shares of common stock
08/31/20
Radio One awarded $431,900 contract modification from NIH
08/25/20
Urban One strength attributed to Washington Business Journal article
Recommendations
Merus price target raised to $32 from $19 at Roth Capital » 10:50
01/19/21
01/19
10:50
01/19/21
10:50
MRUS

Merus

$23.61 /

+0.29 (+1.24%)

, LLY

Eli Lilly

$195.53 /

+4.68 (+2.45%)

Roth Capital analyst Tony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRUS Merus
$23.61 /

+0.29 (+1.24%)

06:37 Today
Eli Lilly, Merus collaborate for novel T-cell re-directing bispecific antibodies
01/12/21
Merus in pacts with medical organizations in Netherlands and Japan for screening
01/07/21
Merus receives fast track designation for Zenocutuzumab from FDA
12/17/20
Merus, Sema4 enter into agreement for Phase 1/2 trial of zenocutuzumab
LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

06:37 Today
Eli Lilly, Merus collaborate for novel T-cell re-directing bispecific antibodies
01/15/21
Eli Lilly reports $30M limited partner investment in Unseen Capital Health Fund
01/11/21
Eli Lilly rises 12.5%
01/11/21
AC Immune, Biogen rise after Lilly reports Alzheimer's study met endpoint
MRUS Merus
$23.61 /

+0.29 (+1.24%)

09/02/20 Roth Capital
Roth Capital keeps Buy on Merus after delay of cancer data
06/26/20 H.C. Wainwright
Merus initiated with a Buy at H.C. Wainwright
05/27/20
Fly Intel: Top five analyst downgrades
05/27/20 RBC Capital
Merus downgraded to Sector Perform from Outperform at RBC Capital
LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

09:52 Today
Fly Intel: Top five analyst upgrades
06:14 Today Mizuho
Eli Lilly upgraded to Buy from Neutral at Mizuho
01/12/21 Truist
Eli Lilly price target raised to $200 from $182 at Truist
01/11/21 JPMorgan
Alzheimer's data a 'significant positive' for Eli Lilly story, says JPMorgan
MRUS Merus
$23.61 /

+0.29 (+1.24%)

08/06/20
Merus reports Q2 EPS (54c), consensus (61c)
LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

12/15/20
Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07
12/15/20
Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32
12/02/20
Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c
10/27/20
Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28
LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

12/30/20
Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says
12/23/20
Judge rules against White House drug pricing rule, Reuters says
11/23/20
EU seeks easier access to generic medicines, Reuters says
11/20/20
Trump to release new rules aimed at lowering drug prices, WSJ reports
MRUS Merus
$23.61 /

+0.29 (+1.24%)

01/07/21
Fly Intel: After-Hours Movers
09/14/20
Fly Insider: Karuna, DexCom among weeks notable insider trades
LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

01/11/21
Fly Intel: Wall Street's top stories for Monday
01/11/21
Fly Intel: Wall Street's top stories at midday
01/11/21
Eli Lilly and Alzheimer's research peers jump after study meets endpoint
01/11/21
Fly Intel: Pre-market Movers
01/26/21
Pharmacovigilance & Risk Management Strategies Virtual Conference
01/28/21
IASLC Virtual World Conference on Lung Cancer
01/29/21
Eli Lilly - LLY
LLY Eli Lilly
$195.53 /

+4.68 (+2.45%)

01/15/21
Eli Lilly call volume above normal and directionally bullish
01/13/21
Early notable gainers among liquid option names on January 13th
01/11/21
Early notable gainers among liquid option names on January 11th
12/09/20
Early notable gainers among liquid option names on December 9th
Conference/Events
G1 Therapeutics management to meet virtually with Roth Capital » 10:49
01/19/21
01/19
10:49
01/19/21
10:49
GTHX

G1 Therapeutics

$21.00 /

+0.18 (+0.86%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTHX G1 Therapeutics
$21.00 /

+0.18 (+0.86%)

12/09/20
G1 Therapeutics says trilaciclib showed improved OS in Phase 2 trial
11/18/20
G1 Therapeutics to present clinical data on trilaciclib, rintodestrant
09/30/20
G1 Therapeutics CEO Mark Velleca to move to new role, John Bailey to succeed
08/17/20
G1 Therapeutics announces FDA acceptance of trilaciclib NDA
GTHX G1 Therapeutics
$21.00 /

+0.18 (+0.86%)

11/17/20 Raymond James
Raymond James downgrades G1 Therapeutics after removing rintodestrant from model
11/17/20 Raymond James
G1 Therapeutics downgraded to Outperform from Strong Buy at Raymond James
07/01/20 Wedbush
G1 Therapeutics price target lowered to $50 from $55 at Wedbush
06/26/20 Roth Capital
G1 Therapeutics initiated with a Buy at Roth Capital
GTHX G1 Therapeutics
$21.00 /

+0.18 (+0.86%)

11/04/20
G1 Therapeutics sees ending year with cash, cash equivalents of $200M-$205M
11/04/20
G1 Therapeutics reports Q3 EPS (31c), consensus (30c)
08/05/20
G1 Therapeutics reports Q2 EPS (83c), consensus (83c)
02/15/21
PDUFA Date for Trilaciclib
01/20/21
G1 Therapeutics
Downgrade
Xerox downgraded to Sell at Cross Research on work from home headwinds » 10:48
01/19/21
01/19
10:48
01/19/21
10:48
XRX

Xerox

$21.60 /

-0.89 (-3.96%)

Cross Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XRX Xerox
$21.60 /

-0.89 (-3.96%)

12/11/20
Xerox announces Xavier Heiss as CFO
11/13/20
Icahn reduces stake in Herbalife, boosts stake in Xerox
10/22/20
DARPA awards Xerox unit PARC contract to expand ocean knowledge
09/11/20
Xerox announces departure of CFO William Osbourn
XRX Xerox
$21.60 /

-0.89 (-3.96%)

09:58 Today Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
07/24/20
Fly Intel: Top five analyst downgrades
XRX Xerox
$21.60 /

-0.89 (-3.96%)

10/27/20
Xerox reports Q3 adjusted EPS 48c, consensus 24c
07/28/20
Xerox reports Q2 EPS 15c, consensus (7c)
XRX Xerox
$21.60 /

-0.89 (-3.96%)

11/09/20
Fly Insider: Xerox, At Home Group among week's notable insider trades
08/19/20
Fly Intel: After-Hours Movers
08/10/20
Fly Insider: Axis Capital, Carvana among week's notable insider trades
XRX Xerox
$21.60 /

-0.89 (-3.96%)

12/02/20
Largest borrow rate increases among liquid names
11/13/20
Early notable gainers among liquid option names on November 13th
09/22/20
Unusual call flow in option market yesterday
09/21/20
Heavy call volume in Xerox as shares slide 5%
Options
Taiwan Semi call volume above normal and directionally bullish » 10:45
01/19/21
01/19
10:45
01/19/21
10:45
TSM

TSMC

$133.54 /

+8.28 (+6.61%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSM TSMC
$133.54 /

+8.28 (+6.61%)

01/14/21
TSMC sees FY21 CapEx $25B-$28B
01/08/21
TSMC reports December revenue NT$117.37B, up 13.6% y/y
11/10/20
TSMC reports October revenue NT$119.3B, up 12.5% y/y
10/08/20
TSMC reports September revenue NT$127.59B, up 24.9% y/y
TSM TSMC
$133.54 /

+8.28 (+6.61%)

01/14/21 Needham
Intel upgraded to Buy from Hold at Needham
01/12/21
Fly Intel: Top five analyst upgrades
01/12/21 Bernstein
TSMC upgraded to Outperform from Market Perform at Bernstein
12/29/20 RBC Capital
Intel intraday move on Third Point news looks 'overdone,' says RBC Capital
TSM TSMC
$133.54 /

+8.28 (+6.61%)

01/14/21
TSMC sees Q1 revenue $12.7B-$13B, consensus $12.62B
01/14/21
TSMC reports Q4 EPS 97c, consensus 94c
10/15/20
TSMC sees Q4 revenue $12.4B-$12.7B, consensus $11.71B
10/15/20
TSMC reports Q3 EPS 90c, consensus 77c
TSM TSMC
$133.54 /

+8.28 (+6.61%)

06:29 Today
TSMC, UMC to see full capacity utilization for 28nm through Q3, DigiTimes says
01/14/21
TSMC pledges to fix global auto chip shortage, FT reports
01/12/21
Intel plans to outsource production of new chips to TSMC, Reuters reports
01/08/21
Intel has talked with TSMC, Samsung about outsourcing chips, Bloomberg reports
TSM TSMC
$133.54 /

+8.28 (+6.61%)

01/14/21
AMD slips as analyst says sell on Gelsinger's return to Intel
01/14/21
Shopify, Intel upgrades among today's top calls on Wall Street
01/14/21
Fly Intel: Pre-market Movers
07/24/20
Fly Intel: Wall Street's top stories for Friday
TSM TSMC
$133.54 /

+8.28 (+6.61%)

12/15/20
Taiwan Semi call volume above normal and directionally bullish
12/11/20
Unusual call flow in option market yesterday
12/10/20
Call sale in Taiwan Semiconductor exits short-term trade for $3.2M loss
12/04/20
Taiwan Semi call volume above normal and directionally bullish
General news
8-Week Bill Announcement to be released at 11:00  10:45
01/19/21
01/19
10:45
01/19/21
10:45
 
General news
4-Week Bill Announcement to be released at 11:00  10:45
01/19/21
01/19
10:45
01/19/21
10:45
 
General news
4-Week Bill Announcement to be released at 11:00  10:45
01/19/21
01/19
10:45
01/19/21
10:45
 
General news
8-Week Bill Announcement to be released at 11:00  10:45
01/19/21
01/19
10:45
01/19/21
10:45
 
Conference/Events
Zoetis management to meet virtually with William Blair » 10:40
01/19/21
01/19
10:40
01/19/21
10:40
ZTS

Zoetis

$163.52 /

+2.59 (+1.61%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZTS Zoetis
$163.52 /

+2.59 (+1.61%)

12/09/20
Zoetis raises quarterly dividend by 25% to 25c per share
11/12/20
Zoetis receives European Commissionmarketing authorization for Librela
ZTS Zoetis
$163.52 /

+2.59 (+1.61%)

11/12/20 Truist
Zoetis price target raised to $170 from $160 at Truist
11/06/20 Barclays
Zoetis price target raised to $189 from $175 at Barclays
09/21/20 Atlantic Equities
Zoetis initiated with an Overweight at Atlantic Equities
08/18/20 Argus
Elanco price target raised to $30 from $26 at Argus
ZTS Zoetis
$163.52 /

+2.59 (+1.61%)

11/05/20
Zoetis sees FY20 EPS $3.76-$3.81 , consensus $3.64
11/05/20
Zoetis reports Q3 EPS $1.10, consensus 91c
11/04/20
Notable companies reporting before tomorrow's open
11/04/20
Notable companies reporting before tomorrow's open
ZTS Zoetis
$163.52 /

+2.59 (+1.61%)

09/12/20
Elanco stock well positioned for gains, Barron's says
08/15/20
Pet business keeps running strong, Barron's says
02/16/21
Zoetis - ZTS
00:00 Today
Zoetis
Hot Stocks
Aclaris Therapeutics trading resumes  10:40
01/19/21
01/19
10:40
01/19/21
10:40
ACRS

Aclaris Therapeutics

$15.44 /

+9.58 (+163.48%)

 
ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$15.44 /

+9.58 (+163.48%)

10:35 Today
Aclaris Therapeutics trading halted, volatility trading pause
07:07 Today
Aclaris Therapeutics announces topline data from Phase 2a trial of ATI-450
11/04/20
Aclaris continues to pursue strategic alternatives, including seeking partners
11/04/20
Aclaris Therapeutics expects to submit investigational NDA for ATI-2138 in 2021
ACRS Aclaris Therapeutics
$15.44 /

+9.58 (+163.48%)

11/04/20
Aclaris Therapeutics reports Q3 EPS (25c), consensus (30c)
08/07/20
Aclaris Therapeutics reports Q2 EPS (28c), consensus (36c)
ACRS Aclaris Therapeutics
$15.44 /

+9.58 (+163.48%)

09:17 Today
Fly Intel: Pre-market Movers
08:00 Today
Aclaris Therapeutics - ACRS
Hot Stocks
Greenrose Axquisition Corporation (Units) trading resumes  10:38
01/19/21
01/19
10:38
01/19/21
10:38
 
Hot Stocks
Aclaris Therapeutics trading halted, volatility trading pause  10:35
01/19/21
01/19
10:35
01/19/21
10:35
ACRS

Aclaris Therapeutics

$14.95 /

+9.09 (+155.12%)

 
ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$14.95 /

+9.09 (+155.12%)

07:07 Today
Aclaris Therapeutics announces topline data from Phase 2a trial of ATI-450
11/04/20
Aclaris continues to pursue strategic alternatives, including seeking partners
11/04/20
Aclaris Therapeutics expects to submit investigational NDA for ATI-2138 in 2021
11/04/20
Aclaris Therapeutics files orphan drug designation for ATI-450-CAPS-201
ACRS Aclaris Therapeutics
$14.95 /

+9.09 (+155.12%)

11/04/20
Aclaris Therapeutics reports Q3 EPS (25c), consensus (30c)
08/07/20
Aclaris Therapeutics reports Q2 EPS (28c), consensus (36c)
ACRS Aclaris Therapeutics
$14.95 /

+9.09 (+155.12%)

09:17 Today
Fly Intel: Pre-market Movers
08:00 Today
Aclaris Therapeutics - ACRS
General news
FX Action: USD-JPY » 10:35
01/19/21
01/19
10:35
01/19/21
10:35

FX Action: USD-JPY has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
General Dynamics awarded $695M U.S. Army Europe contract » 10:34
01/19/21
01/19
10:34
01/19/21
10:34
GD

General Dynamics

$154.53 /

+1.28 (+0.84%)

General Dynamics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GD General Dynamics
$154.53 /

+1.28 (+0.84%)

12/28/20
House of Reps votes 322 to 87 to override Trump's defense bill veto
12/23/20
General Dynamics awarded $4.6B Army contract for battle tanks
12/18/20
General Dynamics awarded $4.62B Army contract to produce Abrams tanks
12/17/20
Trump says will veto defense bill over Section 230
GD General Dynamics
$154.53 /

+1.28 (+0.84%)

11/03/20 Morgan Stanley
Morgan Stanley sees attractive buying opportunity in Defense stocks
10/29/20 Credit Suisse
General Dynamics price target lowered to $140 from $156 at Credit Suisse
10/02/20
Fly Intel: Top five analyst downgrades
10/02/20 Baird
Baird downgrades General Dynamics, sees no 'material' Gulfstream ramp
GD General Dynamics
$154.53 /

+1.28 (+0.84%)

10/28/20
General Dynamics reports Q3 EPS $2.90, consensus $2.86
10/27/20
Notable companies reporting before tomorrow's open
10/27/20
Notable companies reporting before tomorrow's open
07/29/20
General Dynamics lowers FY20 EPS view to $11.00-$11.10 from $11.30-$11.40
GD General Dynamics
$154.53 /

+1.28 (+0.84%)

01/02/21
Congress overturns Trump veto on Defense bill, NPR reports
08/10/20
General Dynamics unit reaches deal to end strike, Reuters reports
GD General Dynamics
$154.53 /

+1.28 (+0.84%)

01/02/21
Week in review: How Trump's policies moved stocks
12/26/20
Week in review: How Trump's policies moved stocks
12/19/20
Week in review: How Trump's policies moved stocks
09/17/20
CVS initiation, Stitch Fix upgrade among today's top calls on Wall Street
01/27/21
General Dynamics - GD
Hot Stocks
Alpha short Mesoblast, expects chronic lower back pain Phase 3 trial to fail » 10:33
01/19/21
01/19
10:33
01/19/21
10:33
MESO

Mesoblast

$9.48 /

-0.21 (-2.17%)

Alpha Exposure said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

01/11/21
Mesoblast announces additional results from DREAM-HF trial
12/17/20
Mesoblast's COVID remestemcel trial not likely to meet mortality reduction goal
12/15/20
Mesoblast trading halted, news pending
12/14/20
Mesoblast reports topline results from DREAM-HF Phase 3 trial
MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

08:01 Today Jefferies
Mesoblast downgraded to Hold from Buy at Jefferies
12/22/20
Fly Intel: Top five analyst downgrades
12/22/20 Maxim
Mesoblast downgraded to Hold from Buy at Maxim
12/18/20 H.C. Wainwright
Mesoblast price target lowered to $16 from $20 at H.C. Wainwright
MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

11/19/20
Mesoblast reports Q3 EPS ($4.21), two estimates (26c)
08/26/20
Notable companies reporting after market close
MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

01/11/21
Fly Intel: Wall Street's top stories for Monday
01/11/21
Fly Intel: Wall Street's top stories at midday
01/11/21
Fly Intel: Pre-market Movers
12/15/20
Fly Intel: Wall Street's top stories for Tuesday
MESO Mesoblast
$9.48 /

-0.21 (-2.17%)

01/11/21
Unusually active option classes on open January 11th
12/22/20
Largest borrow rate increases among liquid names
12/15/20
Largest borrow rate increases among liquid names
12/11/20
Largest borrow rate increases among liquid names
Hot Stocks
Greenrose Axquisition Corporation (Units) trading halted, volatility trading pause  10:33
01/19/21
01/19
10:33
01/19/21
10:33
 
Hot Stocks
State Street sees Q1 NII down about 68% sequentially » 10:26
01/19/21
01/19
10:26
01/19/21
10:26
STT

State Street

$74.47 /

-2.815 (-3.64%)

Expects NII to stabilize…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STT State Street
$74.47 /

-2.815 (-3.64%)

10:26 Today
State Street sees Q1 fee revenue down y/y by low single digits
10:23 Today
State Street board reinitiates share repurchase program of up to $475M in Q1
10:16 Today
State Street faced 'a number of unprecedented challenges' in 2020
08:33 Today
State Street affirms medium-term targets, sees revenue growth 4%-5% with CRD
STT State Street
$74.47 /

-2.815 (-3.64%)

01/11/21 Piper Sandler
State Street price target raised to $81 from $69 at Piper Sandler
01/05/21 Wolfe Research
State Street downgraded to Underperform from Peer Perform at Wolfe Research
01/05/21 Goldman Sachs
State Street downgraded to Neutral from Buy at Goldman Sachs
01/05/21 Goldman Sachs
Northern Trust downgraded to Sell from Neutral at Goldman Sachs
STT State Street
$74.47 /

-2.815 (-3.64%)

07:44 Today
State Street reports Q4 EPS $1.39, consensus $1.56
10/16/20
State Street reports Q3 EPS $1.45, consensus $1.41
10/15/20
Notable companies reporting before tomorrow's open
10/15/20
Notable companies reporting before tomorrow's open
STT State Street
$74.47 /

-2.815 (-3.64%)

12/11/20
State Street weighs strategic options for asset management unit, Bloomberg says
12/11/20
State Street weighs strategic options for asset management unit, Bloomberg says
STT State Street
$74.47 /

-2.815 (-3.64%)

11/30/20
Apple upgrade, Slack downgrade among today's top calls on Wall Street
10/16/20
Fly Intel: Pre-market Movers
02/24/21
22nd Annual Virtual Financial Services Forum
10:00 Today
State Street - STT
Hot Stocks
State Street sees Q1 fee revenue down y/y by low single digits  10:26
01/19/21
01/19
10:26
01/19/21
10:26
STT

State Street

$74.63 /

-2.655 (-3.44%)

 
ShowHide Related Items >><<
STT State Street
$74.63 /

-2.655 (-3.44%)

10:23 Today
State Street board reinitiates share repurchase program of up to $475M in Q1
10:16 Today
State Street faced 'a number of unprecedented challenges' in 2020
08:33 Today
State Street affirms medium-term targets, sees revenue growth 4%-5% with CRD
08:32 Today
State Street sees FY21 NII down 14%-17%
STT State Street
$74.63 /

-2.655 (-3.44%)

01/11/21 Piper Sandler
State Street price target raised to $81 from $69 at Piper Sandler
01/05/21 Wolfe Research
State Street downgraded to Underperform from Peer Perform at Wolfe Research
01/05/21 Goldman Sachs
State Street downgraded to Neutral from Buy at Goldman Sachs
01/05/21 Goldman Sachs
Northern Trust downgraded to Sell from Neutral at Goldman Sachs
STT State Street
$74.63 /

-2.655 (-3.44%)

07:44 Today
State Street reports Q4 EPS $1.39, consensus $1.56
10/16/20
State Street reports Q3 EPS $1.45, consensus $1.41
10/15/20
Notable companies reporting before tomorrow's open
10/15/20
Notable companies reporting before tomorrow's open
STT State Street
$74.63 /

-2.655 (-3.44%)

12/11/20
State Street weighs strategic options for asset management unit, Bloomberg says
12/11/20
State Street weighs strategic options for asset management unit, Bloomberg says
STT State Street
$74.63 /

-2.655 (-3.44%)

11/30/20
Apple upgrade, Slack downgrade among today's top calls on Wall Street
10/16/20
Fly Intel: Pre-market Movers
02/24/21
22nd Annual Virtual Financial Services Forum
10:00 Today
State Street - STT
Options
XPeng call volume above normal and directionally bullish » 10:25
01/19/21
01/19
10:25
01/19/21
10:25
XPEV

Xpeng

$54.20 /

+6.37 (+13.32%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPEV Xpeng
$54.20 /

+6.37 (+13.32%)

01/15/21
Xpeng unveils beta version of Navigation Guided Pilot autonomous driving system
01/11/21
Telenav to provide connected navigation for Xpeng customers in Europe
01/03/21
Xpeng announces vehicle delivery results for December 2020
01/03/21
Xpeng partners with lidar maker Livox
XPEV Xpeng
$54.20 /

+6.37 (+13.32%)

07:11 Today Jefferies
Xpeng initiated with a Hold at Jefferies
01/04/21 Citi
Xpeng partnership with Livox is 'very positive,' says Citi
12/21/20 Wedbush
Tesla price target raised to $715 from $560 at Wedbush
12/14/20
Fly Intel: Top five analyst initiations
XPEV Xpeng
$54.20 /

+6.37 (+13.32%)

11/12/20
Xpeng sees Q4 revenue RMB 2.2B, up 244% year-over-year
11/12/20
Xpeng reports Q3 EPS (32c), deliveries of 8,578
  • 09
    Dec
  • 27
    Aug
XPEV Xpeng
$54.20 /

+6.37 (+13.32%)

12/12/20
Nio, Xeng, Li Auto not the next Tesla, Barron's says
12/02/20
House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says
12/01/20
Lucid Motors finishes 1st part of construction on Arizona factory, Electrek says
XPEV Xpeng
$54.20 /

+6.37 (+13.32%)

10:05 Today
Facebook upgrade, Roku initiation among today's top calls on Wall Street
12/21/20
Tesla under pressure on first trading day on S&P 500 Index
12/21/20
Microsoft, Walmart upgrades among today's top calls on Wall Street
12/19/20
Charged: Deutsche sees multiple EV winners, says buy Xpev
XPEV Xpeng
$54.20 /

+6.37 (+13.32%)

01/12/21
XPeng call volume above normal and directionally bullish
12/31/20
XPeng call volume above normal and directionally bullish
12/29/20
XPeng call volume above normal and directionally bullish
12/15/20
XPeng call volume above normal and directionally bullish
Conference/Events
KBR participates in a webcast with Goldman Sachs » 10:25
01/19/21
01/19
10:25
01/19/21
10:25
KBR

KBR

$31.83 /

+0.29 (+0.92%)

Machinery &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBR KBR
$31.83 /

+0.29 (+0.92%)

06:13 Today
KBR selected as technical advisor for South Korean hydrogen development project
01/14/21
KBR signs alliance agreement with Mura Technology
12/16/20
KBR awarded $49M recompete for improvements, support on CH-47 Chinook
12/14/20
KBR awarded synloop contract by Monolith Materials for Nebraska project
KBR KBR
$31.83 /

+0.29 (+0.92%)

05:51 Today Citi
KBR price target raised to $37 from $30 at Citi
01/15/21 Truist
KBR price target raised to $40 from $34 at Truist
12/18/20 UBS
KBR price target raised to $35 from $28 at UBS
10/27/20 Citi
KBR price target raised to $30 from $28 at Citi
KBR KBR
$31.83 /

+0.29 (+0.92%)

10/29/20
KBR raises FY20 adj. EPS view to $1.60-$1.80 from $1.50-$1.80, consensus $1.68
10/29/20
KBR reports Q3 adj. EPS 44c, consensus 43c
08/06/20
KBR backs FY20 adj. EPS view of $1.50-$1.80, consensus $1.63
08/06/20
KBR reports Q2 adj. EPS 39c, consensus 37c
KBR KBR
$31.83 /

+0.29 (+0.92%)

08/19/20
Fly Intel: Pre-market Movers
02/09/21
42nd Annual Aerospace/Defense & Industrials Virtual Conference
11:00 Today
KBR - KBR
Conference/Events
Pan American Silver to host conference call » 10:25
01/19/21
01/19
10:25
01/19/21
10:25
PAAS

Pan American Silver

$30.11 /

+0.78 (+2.66%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAAS Pan American Silver
$30.11 /

+0.78 (+2.66%)

07:03 Today
Pan American Silver sees FY21 silver production up 35% from last year
11/04/20
Pan American Silver reports Q3 EPS 31c, consensus 38c
09/30/20
Pan American Silver restarts Huaron, Morococha operations in Peru
08/05/20
Pan American Silver reports mineral reserves estimate of 550M ounces of silver
PAAS Pan American Silver
$30.11 /

+0.78 (+2.66%)

01/13/21 Deutsche Bank
Pan American Silver downgraded to Hold from Buy at Deutsche Bank
01/13/21 Deutsche Bank
Pan American Silver downgraded to Hold from Buy at Deutsche Bank
01/11/21 National Bank
Pan American Silver price target raised to C$60 from C$57 at National Bank
10/22/20 National Bank
Pan American Silver price target lowered to C$57 from C$58 at National Bank
PAAS Pan American Silver
$30.11 /

+0.78 (+2.66%)

11/04/20
Pan American Silver reports Q3 adj. EPS 34c, consensus 38c
08/05/20
Pan American Silver reports Q2 adjusted EPS 28c, consensus 6c
11:00 Today
Pan American Silver - PAAS
02/18/21
Pan American Silver - PAAS
PAAS Pan American Silver
$30.11 /

+0.78 (+2.66%)

12/11/20
Pan American Silver put volume heavy and directionally bearish
10/08/20
Pan American Silver put volume heavy and directionally bearish
08/11/20
Unusually active option classes on open August 11th
08/05/20
Pan American Silver call volume above normal and directionally bullish
Conference/Events
JPMorgan healthcare services analysts hold analyst/industry conference call » 10:25
01/19/21
01/19
10:25
01/19/21
10:25

Healthcare Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
JPMorgan Internet analysts to hold an analyst/industry conference call » 10:25
01/19/21
01/19
10:25
01/19/21
10:25

Internet Analysts Anmuth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
State Street board reinitiates share repurchase program of up to $475M in Q1  10:23
01/19/21
01/19
10:23
01/19/21
10:23
STT

State Street

$74.58 /

-2.705 (-3.50%)

 
ShowHide Related Items >><<
STT State Street
$74.58 /

-2.705 (-3.50%)

10:16 Today
State Street faced 'a number of unprecedented challenges' in 2020
08:33 Today
State Street affirms medium-term targets, sees revenue growth 4%-5% with CRD
08:32 Today
State Street sees FY21 NII down 14%-17%
01/07/21
IHS Markit, others to form a new technology-led company, HUB
STT State Street
$74.58 /

-2.705 (-3.50%)

01/11/21 Piper Sandler
State Street price target raised to $81 from $69 at Piper Sandler
01/05/21 Wolfe Research
State Street downgraded to Underperform from Peer Perform at Wolfe Research
01/05/21 Goldman Sachs
State Street downgraded to Neutral from Buy at Goldman Sachs
01/05/21 Goldman Sachs
Northern Trust downgraded to Sell from Neutral at Goldman Sachs
STT State Street
$74.58 /

-2.705 (-3.50%)

07:44 Today
State Street reports Q4 EPS $1.39, consensus $1.56
10/16/20
State Street reports Q3 EPS $1.45, consensus $1.41
10/15/20
Notable companies reporting before tomorrow's open
10/15/20
Notable companies reporting before tomorrow's open
STT State Street
$74.58 /

-2.705 (-3.50%)

12/11/20
State Street weighs strategic options for asset management unit, Bloomberg says
12/11/20
State Street weighs strategic options for asset management unit, Bloomberg says
STT State Street
$74.58 /

-2.705 (-3.50%)

11/30/20
Apple upgrade, Slack downgrade among today's top calls on Wall Street
10/16/20
Fly Intel: Pre-market Movers
02/24/21
22nd Annual Virtual Financial Services Forum
10:00 Today
State Street - STT

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.